Local response to chemoradiation in T4 larynx cancer with cartilage invasion

Laryngoscope

Volumn 121, Issue 1, 2011, Pages 106-110

  Patel, Urjeet A ^a,b   Howell, Lori K ^c  

^a NORTHWESTERN UNIVERSITY   (United States)

^b Jr Hospital of Cook County   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

cartilage invasion; chemoradiotherapy; Head and neck; laryngectomy; larynx cancer; Level of Evidence

Indexed keywords

ADULT; ARTICLE; CANCER ADJUVANT THERAPY; CANCER INVASION; CARTILAGE; CARTILAGE INVASION; CHEMORADIOTHERAPY; CLINICAL ARTICLE; DISTANT METASTASIS; FEMALE; FOLLOW UP; HUMAN; HYPOPHARYNX CANCER; LARYNGECTOMY; LARYNX CANCER; MALE; ONSET AGE; OVERALL SURVIVAL; PRIORITY JOURNAL; RECURRENCE RISK; SEX RATIO; SQUAMOUS CELL CARCINOMA;

CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; FEMALE; HUMANS; HYPOPHARYNGEAL NEOPLASMS; LARYNGEAL CARTILAGES; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; NECK DISSECTION; NEOPLASM INVASIVENESS; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 78651091246     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1002/lary.21181     Document Type: Article

References (13)

1. Adsolon KB., Theodor Billroth in Vienna: 1867-1880. Aust N Z J Surg 1977; 47: 837-844.
2. The Department of Veterans Affairs Laryngeal Cancer Study Group. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 1991; 324: 1685-1689.
3. Forastiere AA, Goepfert H, Maor M, et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 2003; 349: 2091-2098.
4. Forastiere AA., Larynx preservation trials: a critical appraisal. Semin Radic Oncol 1998; 8: 254-261.
5. Vaupel P, Mayer A., Hypoxia in cancer: significance and impact on clinical outcome. Cancer Metastasis Rev 2007; 26: 225-239.
6. Durand RE., Keynote address: the influence of microenvironmental factors on the acgivigy of radiation and drugs. Int J Radiat Oncol Biol Phys 1991; 20: 253-258.
7. Nordsmark M, Bentzen SM, Rudat V, et al. Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study. Radiother Oncol 2005; 77: 18-24.
8. Gourin CG, Conger BT, Sheils WC, et al. The effect of treatment on survival in patients with advanced laryngeal carcinoma. Laryngoscope 2009; 119: 1312-1317.
9. Pfister DG, Laurie SA, Weinstein HT, et al. American Society of Clinical Oncology clinical practice guidelines for the use of larynx-preservation strategies in the treatment of laryngeal cancer. J Clin Oncol 2006; 24: 3693-3704.
10. American Joint Committee on Cancer. AJCC Cancer Staging Manual, 6th edition. Philadelphia, PA: Lippincott -Raven Publishers; 2002.
11. Cooper JS, Porter K, Mallin K, et al. National Cancer Database report on cancer of the head and neck: 10-year update. Head Neck 2009; 31: 748-758.
12. Hoffman HT, Porter K, Karnell LH, et al. Laryngeal cancer in the United States: changes in demographics, patterns of care, and survival. Laryngoscope 2006; 116 (Suppl. 111): 1-13.
13. Patel UA, Patadia MO, Holloway N, Rosen F., Poor radiotherapy compliance predicts persistent regional disease in advanced head/neck cancer. Laryngoscope 2009; 119: 528-533.